1. Home
  2. ITRM vs INLX Comparison

ITRM vs INLX Comparison

Compare ITRM & INLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ITRM
  • INLX
  • Stock Information
  • Founded
  • ITRM 2015
  • INLX 1996
  • Country
  • ITRM Ireland
  • INLX United States
  • Employees
  • ITRM N/A
  • INLX N/A
  • Industry
  • ITRM Biotechnology: Pharmaceutical Preparations
  • INLX EDP Services
  • Sector
  • ITRM Health Care
  • INLX Technology
  • Exchange
  • ITRM Nasdaq
  • INLX Nasdaq
  • Market Cap
  • ITRM 40.0M
  • INLX 40.8M
  • IPO Year
  • ITRM 2018
  • INLX N/A
  • Fundamental
  • Price
  • ITRM $0.77
  • INLX $11.00
  • Analyst Decision
  • ITRM Strong Buy
  • INLX
  • Analyst Count
  • ITRM 1
  • INLX 0
  • Target Price
  • ITRM $9.00
  • INLX N/A
  • AVG Volume (30 Days)
  • ITRM 739.9K
  • INLX 6.6K
  • Earning Date
  • ITRM 11-13-2025
  • INLX 11-12-2025
  • Dividend Yield
  • ITRM N/A
  • INLX N/A
  • EPS Growth
  • ITRM N/A
  • INLX N/A
  • EPS
  • ITRM N/A
  • INLX N/A
  • Revenue
  • ITRM N/A
  • INLX $17,127,854.00
  • Revenue This Year
  • ITRM N/A
  • INLX N/A
  • Revenue Next Year
  • ITRM $482.25
  • INLX $14.19
  • P/E Ratio
  • ITRM N/A
  • INLX N/A
  • Revenue Growth
  • ITRM N/A
  • INLX N/A
  • 52 Week Low
  • ITRM $0.61
  • INLX $8.74
  • 52 Week High
  • ITRM $3.02
  • INLX $16.50
  • Technical
  • Relative Strength Index (RSI)
  • ITRM 59.02
  • INLX 43.78
  • Support Level
  • ITRM $0.66
  • INLX $11.11
  • Resistance Level
  • ITRM $0.81
  • INLX $11.55
  • Average True Range (ATR)
  • ITRM 0.05
  • INLX 0.12
  • MACD
  • ITRM 0.01
  • INLX -0.08
  • Stochastic Oscillator
  • ITRM 63.76
  • INLX 21.28

About ITRM Iterum Therapeutics plc

Iterum Therapeutics PLC is a pharmaceutical company dedicated to maximizing the commercial potential of Orlynvah, an oral-branded penem available in the United States and potentially the first and only oral and intravenous (IV) branded penem available globally. Its product Orlynvah has the potential to be a treatment for complicated urinary tract infections caused by the designated microorganisms, without the presence of known toxicities of some other antibiotics. The company operates in a single business segment, which is the development and commercialization of treatments for drug-resistant bacterial infections.

About INLX Intellinetics Inc.

Intellinetics Inc is a document service and solutions software company serving both the small-to-medium business and governmental sectors. The company's digital transformation products and services are provided through two reporting segments: Document Management and Document Conversion. The Document Management segment consists of solutions involving software platforms, which allow customers to capture and manage all documents across operations such as scanned hard-copy documents and all digital documents including those from Microsoft Office 365, digital images, audio, video, and emails. The company's Document Conversion offerings aid clients as a part of their overall document to convert documents from one medium to another. Majority of revenue is from Document Conversion Segment.

Share on Social Networks: